For Heart: the journey at the forefront of cardiovascular medicine continues by Rahimi, K

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level da... by Rahimi, K

Digital health and the elusive quest for cost savings by Rahimi, K

Bending the blood pressure curve down: are we succeeding? by Rahimi, K

Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation infarction in patients with early invasive treatment: Reply [12] by Rahimi, K

The long and unfinished journey of hyperglycaemia and heart failure research by Rahimi, K

Subclinical atrial fibrillation in need of more assertive evidence by Rahimi, K

Blood pressure management in the 21st century: maximizing gains and minimizing waste. by Rahimi, K, Macmahon, S

Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requir... by Canoy, D, Rahimi, K

Mendelian randomization of plasma lipids and aortic valve stenosis: the importance of outlier variants and population stratification by Nazarzadeh, M, Rahimi, K

Heartbeat: The gut microbiota and heart failure by Otto, C, Rahimi, K

Intensive blood pressure lowering and risk of diabetes: Friend or foe? by Nazarzadeh, M, Rahimi, K

Patients with coronary heart disease and very low blood pressure are at increased risk of cardiovascular events by Rahimi, K, Mohseni, H

A way to a woman's heart might be through her bones by Canoy, D, Rahimi, K

Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects by Nazarzadeh, M, Rahimi, K

Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes. by Rahimi, K, Otto, CM

Self-palpation for detection of paroxysmal atrial fibrillation: much noise with little signal by Rahimi, K, Kirchhof, P

Heterogeneity between genetic variants as a proxy for pleiotropy in mendelian randomization - reply by Nazarzadeh, M, Rahimi, K

Niacin: old habits die hard by Haynes, R, Rahimi, K

Researching the hard-to-reach: a scoping review protocol of digital health research in hidden, marginal and excluded populations by Belt, RV, Rahimi, K, Cai, S